KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Short-term Investments (2016 - 2025)

AbbVie has reported Short-term Investments over the past 14 years, most recently at $28.0 million for Q4 2025.

  • Quarterly Short-term Investments fell 9.68% to $28.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.0 million through Dec 2025, down 9.68% year-over-year, with the annual reading at $28.0 million for FY2025, 9.68% down from the prior year.
  • Short-term Investments was $28.0 million for Q4 2025 at AbbVie, down from $42.0 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $1.5 billion in Q1 2022 and troughed at $1.0 million in Q1 2025.
  • The 5-year median for Short-term Investments is $28.0 million (2022), against an average of $178.8 million.
  • Year-over-year, Short-term Investments soared 6600.0% in 2022 and then plummeted 99.51% in 2023.
  • A 5-year view of Short-term Investments shows it stood at $84.0 million in 2021, then crashed by 66.67% to $28.0 million in 2022, then tumbled by 92.86% to $2.0 million in 2023, then surged by 1450.0% to $31.0 million in 2024, then fell by 9.68% to $28.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Short-term Investments are $28.0 million (Q4 2025), $42.0 million (Q3 2025), and $1.0 million (Q1 2025).